Table 1 Baseline Characteristics
|  | DM (n = 668) | MetS (n = 1122) | Neither DM/MetS (n = 2028) | p value |
|---|---|---|---|---|
Age, years | 66.4 ± 9.0 | 65.7 ± 9.5 | 66.0 ± 9.7 | 0.14 |
Male | 389 (58.2%) | 543 (48.4%) | 1217 (60.0%) | < 0.01 |
Race/ethnicity | ||||
Caucasian | 157 (23.5%) | 499 (44.5%) | 991 (48.9%) | < 0.01 |
African American | 239 (35.8%) | 251 (22.4%) | 467 (23.0%) | < 0.01 |
Chinese | 81 (12.1%) | 108 (9.6%) | 251 (12.4%) | 0.06 |
Hispanic | 191 (28.6%) | 264 (23.5%) | 319 (15.7%) | < 0.01 |
Current smokers | 81 (12.1%) | 135 (12.0%) | 267 (13.2%) | 0.59 |
BMI, kg/m2 | 30.5 ± 6.0 | 30.7 ± 5.0 | 26.6 ± 4.6% | < 0.01 |
SBP, mmHg | 134.0 ± 22.8 | 134.8 ± 20.9 | 126.2 ± 21.0 | < 0.01 |
Cholesterol, mmol/L [mg/dL] | 4.9 ± 1.1 [188.8 ± 40.7] | 5.1 ± 1.0 [195.6 ± 38.1] | 5.1 ± 0.9 [195.4 ± 34.6] | 0.0001 |
HDL-C, mmol/L [mg/dL] | 1.2 ± 0.3 [45.9 ± 13.1] | 1.1 ± 0.3 [42.8 ± 10.5] | 1.4 ± 0.4 [54.6 ± 14.8] | < 0.01 |
10-year ASCVD score, % | 30.5 ± 18.0 | 17.0 ± 12.2 | 15.0 ± 11.9 | < 0.01 |
Hypertension treatment | 435 (65.1%) | 645 (57.5%) | 678 (33.4%) | < 0.01 |
Statin treatment | 217 (32.5%) | 254 (22.6%) | 376 (18.5%) | < 0.01 |
CAC Agatston score | 345.9 ± 645.3 | 241.1 ± 494.4 | 237.4 ± 485.4 | < 0.01 |
CAC volume score, mm3 | 307.8 ± 545.2 | 213.9 ± 410.4 | 208.5 ± 402.1 | < 0.01 |
CAC density | 2.59 ± 0.76 | 2.53 ± 0.75 | 2.60 ± 0.76 | 0.03 |